Poolbeg Pharma says research confirms $10B plus opportunity for POLB 001 in cancer immunotherapies

By Proactive Investors / February 12, 2024 / www.youtube.com / Article Link

Poolbeg Pharma Plc chief business officer David Allmond joined Proactive's Stephen Gunnion with details of independent ...

Recent News

Gold stocks gain on move back into metal

October 12, 2026 / www.canadianminingreport.com

Silver stocks gain over past year even as metal price weak

October 12, 2026 / www.canadianminingreport.com

Copper price estimates boosted by AOCE

October 05, 2026 / www.canadianminingreport.com

AOCE makes significant changes to metal estimates

October 05, 2026 / www.canadianminingreport.com

Big Gold still struggling overall in 2026

September 28, 2026 / www.canadianminingreport.com

See all >